I
Iswarya Fertility Center
Comprehensive fertility, IVF, and assisted reproductive technology centers.
About Iswarya Fertility Center
Iswarya Fertility Center is a major network of fertility clinics in India, primarily focused on providing assisted reproductive technology (ART) to couples. Founded in 1986 by Dr. S. Chandralekha and Dr. Veluswamy, the organization grew for nearly four decades without external funding, establishing itself as a significant player in the South Indian healthcare market before securing its first growth investment in July 2026. The company was established in Chennai with the mission to make advanced fertility treatments accessible. Dr. S. Chandralekha, the founder and Chief Clinical Officer, is an experienced gynecologist and infertility specialist who has been practicing for over 30 years. A gold medalist from Coimbatore Medical College, her academic excellence drove her to establish one of India's first rural IVF centers. The leadership team also includes Dr. Arun Muthuvel as Managing Director, a reproductive medicine specialist with international training from institutions like Boston IVF (affiliated with Harvard University) and the Cleveland Clinic. His focus is on expanding the company's presence into underserved regions and enhancing clinical outcomes. Iswarya's business model is centered on a hub-and-spoke network of over 85 centers across eight states, which it states combines clinical depth with cost efficiency. The company operates on a fee-for-service basis, providing a broad spectrum of treatments to its clients. Services range from foundational procedures like Intrauterine Insemination (IUI) and In-Vitro Fertilization (IVF) to more advanced technologies such as Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Diagnosis (PGD), and surgical sperm retrieval for conditions like azoospermia. The centers also manage egg donation programs, fertility preservation (embryo freezing), and various laparoscopic surgeries. To make treatments more accessible, the company offers EMI options. Over its history, Iswarya has served more than 300,000 couples. A significant milestone occurred in July 2026 when the company raised over ₹350 crore (nearly $37 million) from OrbiMed Asia. This capital is intended to fund the establishment of new centers, upgrade clinical infrastructure, and invest in digital capabilities to support further growth across India and eventual international expansion. The company utilizes technologies such as AI-driven monitoring and camera-witnessing systems in its labs to ensure sample integrity and optimal conditions for embryo culture.
Source: Dealroom company dataNews
Open roles
Iswarya Fertility Center in the Chennai ecosystem
The Iswarya Fertility Center office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Iswarya Fertility Center on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Iswarya Fertility Center on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.



